Ellie Leick

Dr. Omid Hamid discusses combining targeted drugs and immunotherapy, the role of surgery and ongoing research efforts in melanoma.

A large study at the University of Rochester Medical Center’s Wilmot Cancer Institute sought out to get to the root of the causes of cancer-related cognitive impairment and who may be at risk.

A team of researchers at the University of Buffalo investigated the role that patients' stress and anxiety plays in deciding on treatment.

Michael J. Mauro, M.D., discusses advances in treating myeloproliferative disorders.

Many patients with cancer do not qualify for clinical trials because of comorbidities or other health problems. However, a recent study found that many of these patients can actually benefit from trials.

A simple blood test may be able to notify patients and their health care providers if their oropharyngeal cancer is recurring.

When zoledronic acid use happens less frequently, patients with breast cancer, prostate cancer or multiple myeloma with bone metastases did not see an increase in skeletal-related events.

Andrew D. Zelenetz, M.D., Ph.D. weighs in on recent research and the future of treating hematologic malignancies.

Overall, melanoma incidences increased over the past year in the United States, but deaths did not, according to a recent study which stratified the data by state.

Serving as a caregiver to a loved one with cancer is particularly challenging, and training could make the experience more manageable.

Jorge Garcia offers insight about the benefits of Cabometyx and the drug's impact on RCC.

A recent study found that certain genetic mutations could play a role in cisplatin-induced hearing loss.

CURE spoke with Celestia S. Higano on common problems that survivors of prostate cancer face.

Chemotherapy-induced nausea and vomiting can be reduced with certain FDA-approved drugs.

Two recent studies showed that insurance disparities could end up being treatment and survival disparities for patients with cancer.

CURE spoke with the founder of CORAL 65 on the unique issues older patients with cancer face.

Tweet chats are no longer just a social way to share ideas. Now, cancer innovators have the opportunity to win grants that will help them develop their ideas on how to improve care.

Ruben Mesa discusses Jakafi's potential in treating myelofibrosis.

Olga Ivanov talks with CURE about the multiple side effects, including changes in sex drive, that happen after women have risk-reducing surgery.

A new online tool can help patients with prostate cancer determine if active surveillance is the right decision.

Because of a nation-wide shortage of oncologists, nurses and nurse practitioners are becoming the key leaders in survivorship care.

CURE spoke with Stanley Yap about how physicians can improve care for patients with muscle-invasive bladder cancer.

When Gilbert Eugene Crawford, Sr. was diagnosed with prostate cancer, his daughter and primary caregiver Valerie Crawford-Schiele was shocked to discover just how few resources existed for patients with prostate cancer and their caregivers.

The traditional Chinese act of acupressure can reduce fatigue for survivors of breast cancer.

A tango program for cancer survivors is showing to have benefits far beyond developing graceful dance moves.

CURE spoke with Liz Salmi on connecting people with brain tumors via social media.

The number of older citizens within the United States is quickly growing, and the effect of that phenomenon on the health care system is referred to by many as a “silver tsunami.”

Genetic mutations that were traditionally known for breast and ovarian cancer are now being examined for their role in pancreatic cancer.

The HPV vaccine can prevent cancer, and is especially important for survivors of childhood cancer, who are more prone to developing second cancers.

A recent phase 1 study shows promise for the treatment of bladder cancer.